Table 12:
Accuracy of CAP Versus Biopsy for the Diagnosis of Liver Steatosis, by Histological Steatosis Stage
| Author, Year | Study Details | Results | ||||
|---|---|---|---|---|---|---|
| Population | Steatosis Stage | Studies (Patients), n | AUROC (95% CI) | Sensitivity (95% CI) | Specificity (95% CI) | |
| Shi et al, 2014 (41) | Multiple diseasesa | ≥ S1 | 8 (NR) | 0.85 (0.81–0.88) | 0.78 (0.69–0.84) | 0.79 (0.68–0.86) |
| ≥ S2 | 7 (NR) | 0.88 (0.85–0.91) | 0.85 (0.75–0.92) | 0.79 (0.71–0.85) | ||
| ≥ S3 | 7 (NR) | 0.87 (0.84–0.90) | 0.83 (0.76–0.89) | 0.79 (0.68–0.87) | ||
Abbreviations: AUROC, area under the receiving operator characteristic; CAP, controlled attenuation parameter; CI, confidence interval; NR, not reported.
a
Aggregate results compiling multiple causes of liver diseases as reported in original studies; summary of included diseases provided in Table 2.